TNPO2 and neurodevelopmental disorder: The last case was affected by two de novo diseases: a recurrent microdeletion and an additional dominant TNPO2-neurodevelopmental disorder; interestingly, only 15 other patients carrying de novo pathogenic variants in TNPO2 have been reported to date [21].